ANI Pharmaceuticals, Inc. (ANIP)
75.02
+1.12
(+1.52%)
USD |
NASDAQ |
Mar 02, 11:28
ANI Pharmaceuticals EPS Diluted (Quarterly) : 1.172 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Castle Biosciences, Inc. | -0.0795 |
| Arcutis Biotherapeutics, Inc. | 0.1282 |
| Allogene Therapeutics, Inc. | -0.1864 |
| Amicus Therapeutics, Inc. | 0.0054 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 25.39M |
| Revenue (Quarterly) | 247.06M |
| Total Expenses (Quarterly) | 221.67M |
| Enterprise Value | 1.993B |
| Gross Profit Margin (Quarterly) | 50.26% |
| Profit Margin (Quarterly) | 10.28% |
| Earnings Yield | 4.47% |
| Operating Earnings Yield | 5.20% |
| Normalized Earnings Yield | 2.989 |